LANCRIX

CI994, ≥99%

Catalog No. 737363

Identification
SynonymsAcetyldinaline, Tacedinaline
CAS No.112522-64-2
M.F.

C15H15N3O2

M.W. 269.30
MDL No.MFCD00866266
Technical Data
AppearanceWhite powder
Assay≥99% HPLC
SolubilityDMSO
Storage-20℃
ApplicationCI994 is an oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells. It is used for combination therapy for selected tumors including non-small cell lung, pancreatic, breast, and colorectal cancers. It acts as a histone deacetylase inhibitor.
Safety Data
SymbolGHS07
Hazard StatementsH319
Precautionary StatementsP305 + P351 + P338
Hazard SymbolsXi
Risk StatementsR36
Safety StatementsS26
WGK Germany3
RTECSCU8702023
Reference

Pontiki, E. et al. Med, Res. Rev., 32, 1, (2012)
Gediya, L.K., et al. Bioorg. Med. Chem. 16, 3352-3360, (2008)
Hubeek, I., et al. Oncol. Rep. 19, 1517-1523, (2008)
Pauer, L.R. et al. Cancer Invest., 22, 886, (2004)
Nemunaitis, J.J. et al. Cancer J., 9, 58. (2003)

Availability: Ships in 1-3 days

For research use only.

Inquire

(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject 737363, CI994, ≥99%, 112522-64-2
*Message
*Code If it’s not clear, please click on the picture to change one.